Multiomics in the Era of Translational and Precision Medicine
Genomics has provided actionable clinical information, helping diagnose rare diseases, identify tumor mutations linked to treatment resistance, and find new drug targets.
But clinicians often face a problem: two tumors with the same mutation can respond differently to chemotherapy, and two patients with the same symptoms can carry entirely different DNA alterations.
The reason lies in the complexity of disease regulation. Changes in splicing, transcription,...
The precisionFDA and Georgetown-ICBI Challenge is Live!
The goal of this challenge is to advance techniques for the prognosis and treatment of brain tumors by asking participants to develop machine learning...
The precisionFDA BioCompute Object (BCO) App-a-thon has been extended to October 18,
The precisionFDA BioCompute Object (BCO) App-a-thon, in partnership with George Washington University and CBER HIVE, has been extended! The challenge...
FDA’s Office of Health Informatics is excited to announce that precisionFDA, a secure cloud-based collaborative platform for advancing regulatory science...
PrecisionFDA is launching the NCI-CPTAC Mislabeling Challenge!
The FDA and NCI-CPTAC have joined forces to launch a challenge to encourage the development and evaluation of computational algorithms that can accurately...